Postherpetic neuralgia
Therapeutic area
Neurology
Rare disease
No
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Postherpetic neuralgia
- Alternative names
- postherpetic neuralgia
- Therapeutic area
- Neurology
- Disease mechanisms
- Acquired
Sources for recorded values
- All therapeutic areas
- Neurology
Sources for recorded values
- Severity
- Moderate
- MONDO ID
- MONDO:0041052
- Parent condition
- MONDO:0021677
Related records
Broader conditions (14)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Nervous system disorder
- Neuralgia
- Neurological pain disorder
- Neuromuscular disease
- Peripheral nervous system disorder
- Peripheral neuropathy
- Post-infectious disorder
- Post-infectious neuralgia
- Post-viral disorder
Trials (197)
- 3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN)
- A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
- A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)
- A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
- A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment
- A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia
- A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury
- A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
- A Comparative Study of KHK6188
- A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
- A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome
- A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)
- A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
- A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
- A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).
- A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
- A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
- A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
- A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
- A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)
Approved drugs (3)
- Gabapentin
- Lidocaine
- Varicella-zoster immune globulin
Drugs in development (51)
- ADL-5747 Phase 2
- Amitriptyline Phase 2
- ASP-8477 Phase 2
- Aspirin Phase 1
- ATX08-001 Phase 2
- AZD1386 Phase 2
- Brivaracetam Phase 2
- Bupivacaine Phase 3
- Bupivacaine hydrochloride Phase 1
- Capsaicin Phase 2
- Carisbamate Phase 2
- CNV2197944 Phase 2
- Crisugabalin Phase 3
- DWP05195 Phase 2
- Eslicarbazepine acetate Phase 3
- Ezogabine Phase 2
- Fulranumab Phase 2
- Funapide Phase 2
- Gabapentin enacarbil Phase 2
- KAI-1678 Phase 2
Other linked drugs (10)
- Acyclovir
- Dexamethasone
- Duloxetine
- Esketamine
- Famciclovir
- Mecobalamin
- Methylcobalamin
- Ropivacaine
- Tramadol
- Valacyclovir hydrochloride